(ZGN) Ermenegildo Zegna - Ratings and Ratios
Menswear, Womenwear, Footwear, Leather, Accessories
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.57% |
| Yield on Cost 5y | 1.44% |
| Yield CAGR 5y | 14.47% |
| Payout Consistency | 92.4% |
| Payout Ratio | 38.1% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 35.9% |
| Value at Risk 5%th | 54.7% |
| Relative Tail Risk | -7.44% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.98 |
| Alpha | 18.56 |
| CAGR/Max DD | 0.00 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.388 |
| Beta | 1.133 |
| Beta Downside | 1.030 |
| Drawdowns 3y | |
|---|---|
| Max DD | 60.99% |
| Mean DD | 29.19% |
| Median DD | 31.32% |
Description: ZGN Ermenegildo Zegna January 14, 2026
Ermenegildo Zegna N.V. (NYSE:ZGN) designs, manufactures, markets, and distributes a full spectrum of luxury apparel and accessories for men, women, and children, including menswear, womenswear, footwear, leather goods, eyewear, jewelry, fragrances, and home-design products. Its portfolio is anchored by the ZEGNA, Thom Browne, and TOM FORD FASHION brands, and sales are executed through a global network of brick-and-mortar boutiques and e-commerce platforms.
Key recent metrics: FY 2023 revenue reached €1.32 billion, up ~12 % YoY, driven by a 20 % increase in digital sales and strong demand in the Asia-Pacific region, where the brand’s luxury leisurewear outperformed the broader market. Operating margin expanded to 14 % as the company leveraged higher-margin bespoke tailoring and the recent acquisition of the TOM FORD FASHION label, which added ~€300 million of incremental revenue in its first year. The luxury apparel sector is currently benefiting from a 5-6 % CAGR in discretionary spending among high-net-worth consumers, while macro-headwinds such as inflation and currency volatility remain material risks.
For a deeper, data-driven valuation framework, see the ZGN profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (195.7m TTM) > 0 and > 6% of Revenue (6% = 232.5m TTM) |
| FCFTA 0.14 (>2.0%) and ΔFCFTA 8.25pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 8.66% (prev 8.69%; Δ -0.04pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.20 (>3.0%) and CFO 552.6m > Net Income 195.7m (YES >=105%, WARN >=100%) |
| Net Debt (875.1m) to EBITDA (510.2m) ratio: 1.72 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.42 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (255.5m) change vs 12m ago 2.08% (target <= -2.0% for YES) |
| Gross Margin 66.24% (prev 63.92%; Δ 2.31pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 141.1% (prev 114.5%; Δ 26.55pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 9.74 (EBITDA TTM 510.2m / Interest Expense TTM 36.5m) >= 6 (WARN >= 3) |
Altman Z'' 2.82
| (A) 0.12 = (Total Current Assets 1.14b - Total Current Liabilities 801.8m) / Total Assets 2.73b |
| (B) 0.26 = Retained Earnings (Balance) 703.0m / Total Assets 2.73b |
| (C) 0.13 = EBIT TTM 355.5m / Avg Total Assets 2.75b |
| (D) 0.29 = Book Value of Equity 507.9m / Total Liabilities 1.77b |
| Total Rating: 2.82 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 82.20
| 1. Piotroski 7.0pt |
| 2. FCF Yield 12.30% |
| 3. FCF Margin 9.78% |
| 4. Debt/Equity 1.17 |
| 5. Debt/Ebitda 1.72 |
| 6. ROIC - WACC (= 12.69)% |
| 7. RoE 22.40% |
| 8. Rev. Trend 72.72% |
| 9. EPS Trend 10.56% |
What is the price of ZGN shares?
Over the past week, the price has changed by +0.93%, over one month by +4.65%, over three months by +23.29% and over the past year by +43.76%.
Is ZGN a buy, sell or hold?
- Strong Buy: 2
- Buy: 1
- Hold: 3
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the ZGN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 11.6 | 7.1% |
| Analysts Target Price | 11.6 | 7.1% |
| ValueRay Target Price | 11.7 | 8% |
ZGN Fundamental Data Overview January 09, 2026
P/E Trailing = 24.3256
P/E Forward = 23.2558
P/S = 1.3884
P/B = 2.5686
Beta = 0.754
Revenue TTM = 3.88b EUR
EBIT TTM = 355.5m EUR
EBITDA TTM = 510.2m EUR
Long Term Debt = 174.4m EUR (from longTermDebt, last quarter)
Short Term Debt = 305.7m EUR (from shortTermDebt, last quarter)
Debt = 1.03b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 875.1m EUR (from netDebt column, last quarter)
Enterprise Value = 3.08b EUR (2.28b + Debt 1.03b - CCE 231.2m)
Interest Coverage Ratio = 9.74 (Ebit TTM 355.5m / Interest Expense TTM 36.5m)
EV/FCF = 8.13x (Enterprise Value 3.08b / FCF TTM 379.2m)
FCF Yield = 12.30% (FCF TTM 379.2m / Enterprise Value 3.08b)
FCF Margin = 9.78% (FCF TTM 379.2m / Revenue TTM 3.88b)
Net Margin = 5.05% (Net Income TTM 195.7m / Revenue TTM 3.88b)
Gross Margin = 66.24% ((Revenue TTM 3.88b - Cost of Revenue TTM 1.31b) / Revenue TTM)
Gross Margin QoQ = 67.48% (prev 66.81%)
Tobins Q-Ratio = 1.13 (Enterprise Value 3.08b / Total Assets 2.73b)
Interest Expense / Debt = 1.54% (Interest Expense 15.9m / Debt 1.03b)
Taxrate = 29.57% (20.1m / 68.0m)
NOPAT = 250.4m (EBIT 355.5m * (1 - 29.57%))
Current Ratio = 1.42 (Total Current Assets 1.14b / Total Current Liabilities 801.8m)
Debt / Equity = 1.17 (Debt 1.03b / totalStockholderEquity, last quarter 885.4m)
Debt / EBITDA = 1.72 (Net Debt 875.1m / EBITDA 510.2m)
Debt / FCF = 2.31 (Net Debt 875.1m / FCF TTM 379.2m)
Total Stockholder Equity = 873.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.12% (Net Income 195.7m / Total Assets 2.73b)
RoE = 22.40% (Net Income TTM 195.7m / Total Stockholder Equity 873.6m)
RoCE = 33.93% (EBIT 355.5m / Capital Employed (Equity 873.6m + L.T.Debt 174.4m))
RoIC = 19.97% (NOPAT 250.4m / Invested Capital 1.25b)
WACC = 7.28% (E(2.28b)/V(3.31b) * Re(10.09%) + D(1.03b)/V(3.31b) * Rd(1.54%) * (1-Tc(0.30)))
Discount Rate = 10.09% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.04%
[DCF Debug] Terminal Value 81.45% ; FCFF base≈290.0m ; Y1≈304.4m ; Y5≈355.0m
Fair Price DCF = 24.94 (EV 7.21b - Net Debt 875.1m = Equity 6.34b / Shares 254.1m; r=7.28% [WACC]; 5y FCF grow 5.37% → 2.90% )
EPS Correlation: 10.56 | EPS CAGR: 3.22% | SUE: 0.0 | # QB: 0
Revenue Correlation: 72.72 | Revenue CAGR: 34.61% | SUE: N/A | # QB: 0
EPS next Year (2026-12-31): EPS=0.42 | Chg30d=-0.001 | Revisions Net=-2 | Growth EPS=+12.8% | Growth Revenue=+4.8%
Additional Sources for ZGN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle